These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 23159218

  • 1. Emerging concepts in the management and treatment of osteonecrosis of the jaw.
    Ruggiero SL.
    Oral Maxillofac Surg Clin North Am; 2013 Feb; 25(1):11-20, v. PubMed ID: 23159218
    [Abstract] [Full Text] [Related]

  • 2. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T.
    Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
    [Abstract] [Full Text] [Related]

  • 3. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P, Atanes-Bonome A, Ríos-Lage P, Atanes-Sandoval AD.
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [Abstract] [Full Text] [Related]

  • 4. [Prevention and treatment of bisphosphonate-induced jaw bone osteonecrosis. II].
    Fogorv Sz; 2014 Sep; 107(3):106-7. PubMed ID: 25509512
    [No Abstract] [Full Text] [Related]

  • 5. FPIN's clinical inquiries. Risks of bisphosphonate use.
    Scott MA, Meadowcraft L, Skolnik D.
    Am Fam Physician; 2013 Nov 15; 88(10):697, 702. PubMed ID: 24364486
    [No Abstract] [Full Text] [Related]

  • 6. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J, McCauley LK.
    J Evid Based Dent Pract; 2012 Sep 15; 12(3 Suppl):233-47. PubMed ID: 23040351
    [Abstract] [Full Text] [Related]

  • 7. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S, Shenoy VK, Eachampati P, Uppal N.
    Gerodontology; 2012 Sep 15; 29(3):177-87. PubMed ID: 22486711
    [Abstract] [Full Text] [Related]

  • 8. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M, Antić S, Jelovac DB, Zarev AI, Petrović MB, Golubović M, Antunović M.
    Vojnosanit Pregl; 2014 Aug 15; 71(8):772-6. PubMed ID: 25181838
    [No Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Piccioli A.
    Eur J Orthop Surg Traumatol; 2015 Jan 15; 25(1):29-37. PubMed ID: 24037511
    [Abstract] [Full Text] [Related]

  • 10. [Advances in the research of bisphosphonate-associated osteonecrosis of the jaws].
    Ruan M, Ji T, Zhang CP.
    Shanghai Kou Qiang Yi Xue; 2006 Dec 15; 15(6):663-7. PubMed ID: 17533726
    [Abstract] [Full Text] [Related]

  • 11. [The risk of bisphosphonate-related osteonecrosis of the jaw].
    Polymenidi I, Trombetti A, Carballo S.
    Rev Med Suisse; 2014 Oct 15; 10(446):1930-4. PubMed ID: 25438377
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonate-related osteonecrosis of the jaw: an overview.
    Ruggiero SL.
    Ann N Y Acad Sci; 2011 Feb 15; 1218():38-46. PubMed ID: 20946580
    [Abstract] [Full Text] [Related]

  • 13. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A.
    Clin Calcium; 2012 Jan 15; 22(1):83-90. PubMed ID: 22201103
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L, Wood NH, Khammissa RA, Chikte UM, Bouckaert M, Lemmer J.
    SADJ; 2011 Feb 15; 66(1):30-2. PubMed ID: 21510174
    [Abstract] [Full Text] [Related]

  • 15. The effects of osteoclast modifiers on the oral cavity: a review for prescribers.
    Epstein MS, Epstein JB, Ephros HD.
    Curr Opin Support Palliat Care; 2012 Sep 15; 6(3):337-41. PubMed ID: 22871978
    [Abstract] [Full Text] [Related]

  • 16. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A, Atlas J.
    Oral Maxillofac Surg Clin North Am; 2014 May 15; 26(2):231-7. PubMed ID: 24794267
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb 15; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 18. An office-based approach to the diagnosis and management of osteonecrosis.
    Ruggiero SL.
    Atlas Oral Maxillofac Surg Clin North Am; 2013 Sep 15; 21(2):167-73. PubMed ID: 23981492
    [No Abstract] [Full Text] [Related]

  • 19. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G, Collangettes D, Dillies AF, Calvet L, Tournilhac O, Bay JO, Mahammedi H.
    Bull Cancer; 2015 Dec 15; 102(12):1010-9. PubMed ID: 26607453
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.